TEDOR Pharma Services is a science-driven Contract, testing, Drug Development, and Manufacturing Organization (CDMO). partnering with your team to provide solutions and services for analytical testing; drug dosage development; clinical supply, packaging, distribution; and commercial manufacturing. DEA-scheduled products I-V; high potency; powder biologics; small manufacturing batches and orphan drugs for life science customers. TEDOR has helped customers meet their project timelines, achieve regulatory approvals, and solve formulation challenges. TEDOR Pharma employs skilled and specialized experts that support a wide range of capabilities that include: •Drug Product Development • Analytical Testing • Quality Assurance • Legal Compliance • Regulatory Filing • cGMP Manufacturing • Commercialization Our dynamic work environment provides a great opportunity to learn and grow professionally. We offer competitive wages and benefits, and our employees have the opportunity to drive innovative technologies, setting industry trends. TEDOR is an Equal Opportunity Employer.
Looking for a particular Tedor Pharma, Inc. employee's phone or email?
The Tedor Pharma, Inc. annual revenue was $6 million in 2026.
Laura Iorio is the CEO of Tedor Pharma, Inc..
31 people are employed at Tedor Pharma, Inc..
Tedor Pharma, Inc. is based in Cumberland, Rhode Island.
The NAICS codes for Tedor Pharma, Inc. are [32541, 325, 3254, 32].
The SIC codes for Tedor Pharma, Inc. are [283, 28].